Warning: include(/home/ibtimes.com/in/banner/htm/article_topbutton.htm) [function.include]: failed to open stream: No such file or directory in /home/ibtimes.com/in/banner/banner.php on line 8
Warning: include() [function.include]: Failed opening '/home/ibtimes.com/in/banner/htm/article_topbutton.htm' for inclusion (include_path='.:/usr/local/PEAR') in /home/ibtimes.com/in/banner/banner.php on line 8
Biocon teams up with Abraxis BioScience, launches breast cancer drug Abraxane in India India's top biotechnology company Biocon Ltd has teamed up with US-based Abraxis BioScience, Inc. to announce the launch of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in India for the treatment of breast cancer after failure of combination therapy for metastatic disease or relapse within six months of adjuvant chemotherapy. 20 Jul 2008
Biocon's FY08 net profit up 12.5 percent, declares 1:1 share bonus India's leading biotechnology company, Biocon Ltd. has posted a 12.5 percent rise in net profit for the fiscal year ended March 31, 2008, and has boosted market confidence by saying it expects good returns on its investment in the coming years. 25 Apr 2008
4.
Biocon to buy 70 percent stake in German pharma co. for €30 million India's top biotechnology firm, Biocon Ltd announced Monday that it has reached an agreement with German pharmaceutical company AxiCorp GmbH to acquire 70 percent stake in the latter for €30 million. 11 Feb 2008
5.
Indian Cos. tap foreign resumes India continues to hire and train for its growing information technology industry, but a talent shortage is forcing it to look overseas. 07 Dec 2007
6.
Biocon Sept quarter net up, eyes overseas listing India's top biotechnology firm, Biocon Ltd, on Thursday posted a 19 percent rise in quarterly net profit on improved sales of insulin and as it won more research outsourcing services contracts. 18 Oct 2007
7.
Biocon inks JV with Neopharma for Middle-East foray India's leading biotechnology enterprise, Biocon, has inked an agreement with Abu Dhabi-based Neopharma to establish a joint venture company NeoBiocon to develop specialty bio-pharmaceutical products and provide biotherapeutics for the United Arab Emirates (UAE) market. 02 Aug 2007
Global pharma outsourcing market to touch $ 53 billion by 2010 With a slowdown in patented drugs sales and drying R&D pipelines, global pharma companies are increasingly tapping the low-cost global pharmaceutical outsourcing market on research and manufacturing, which, according to industry sources, currently stands at $ 24 billion and could reach $ 53 billion by 2010. 31 May 2006
10.
Karnataka cancels Biocon's drug manufacturing licence The state government of Karnataka has announced the cancellation of the licence given to biotech major Biocon India Limited for manufacture of 'methylcobalamin,' a drug used in treatment of neurological problems, citing violation of import norms. 11 Apr 2006
